Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when OSCR files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsOscar Health reaffirms 2026 guidance at Goldman Sachs healthcare conference
Filed June 8, 2026 · Period ending June 8, 2026 · ~1 min read
Key Changes
-
low
Company will participate in Goldman Sachs healthcare conference on June 8, 2026 at 11:20 AM ET, providing a business update and reaffirming full year 2026 financial guidance originally issued February 10, 2026.
Item 7.01 verify on EDGAR →
Summary
Oscar Health filed a routine 8-K to disclose its participation in the Goldman Sachs 47th Annual Global Healthcare Conference on June 8, 2026. The company plans to reaffirm its full year 2026 financial guidance, which was originally provided in its February 10, 2026 earnings release. This filing is a standard Regulation FD disclosure ensuring all investors have equal access to information shared at the conference.
For retail investors, this is a procedural filing with no material impact. The company is not changing its financial outlook, merely restating previously announced targets. The lack of any guidance revision suggests management remains confident in its February projections. Investors should monitor whether the company maintains this guidance through subsequent quarterly earnings reports, particularly if industry conditions or enrollment trends shift materially in coming months.
Section-by-Section Diff
Event · Item 7.01 — Regulation FD Disclosure
Item 7.01 — Regulation FD Disclosure filed; see Key Changes for terms.
Show 1 minor / wording change
Added in current filing · verify on EDGAR →
Oscar Health, Inc. (the “Company”) will participate in a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference (the “Conference”) on June 8, 2026 at approximately 11:20 AM ET. At the Conference, the Company plans to provide a business update and reaffirm its full year 2026 guidance, as previously provided in its financial results press release dated February 10, 2026.
The company is announcing its participation in an investor conference where it will reaffirm previously issued full year 2026 financial guidance. This is a routine disclosure under Regulation FD to ensure all investors have equal access to the conference presentation. The guidance itself is not being changed, only reaffirmed.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 8, 2026 · How we verify